Developer docs
API playgroundTry for free, no card

Search company profiles

CD Bioparticles

Full company profile

uuid0006hia

Namestring
CD Bioparticles
Legal namestring
CD Bioparticles
Company typeenum
Private
Founded yearint
2009
Descriptiontext

CD Bioparticles is a privately held US-based manufacturer and supplier of magnetic particles, nanoparticles, and bead-based kits serving pharmaceutical, biotechnology, clinical diagnostics, and environmental testing laboratories. Headquartered in Shirley, New York, with an additional New York presence tied to its 2026 vaccine services launch, the company has operated for over 10 years and reports serving thousands of research and commercial clients globally across North America and Europe. Its portfolio spans Absolute Mag™ magnetic particles (streptavidin, affinity, ion-exchange, lanthanide-based, silica), a broad nanoparticle catalog (spherical gold, gold nanorods, silver, silica, quantum dots, upconverting nanoparticles, titania, polymer, nanozymes, cellulose), MagIso™ nucleic acid isolation particles, fluorescence-encoded multiplex beads capable of detecting up to 100 analytes simultaneously, and a comprehensive line of beads-based kits covering chromatin immunoprecipitation, ELISA, virus purification, cell isolation, and immunoprecipitation. Proprietary platform technologies include an organ-targeted lipid nanoparticle (LNP) system using novel structured cationic and ionizable lipids for extrahepatic RNA delivery and an outer membrane vesicle (OMV) engineering platform that combines synthetic biology with bacterial genome editing to produce bacterial vaccines at claimed production costs at least five times lower than conventional methods.

The company operates a hybrid go-to-market combining direct e-commerce sales through its multilingual storefront (English, German, Japanese, Korean) with a distributor network covering 11 countries and a sales-led motion for custom services such as antibody immobilization, immunomagnetic bead preparation, drug targeting and delivery, assay development (latex immunoturbidimetric, colloidal gold lateral flow, quantum dot lateral flow, chemiluminescent immunoassay), characterization, and animal model validation. Revenue is generated primarily through transactional catalog product sales (one-time purchase, pay-as-you-go with promotional bundles such as the BOGO Magnetic Rack Separator offer) and fee-for-service custom engagements, with all pricing quote-based and not publicly disclosed. Recent strategic activity has been concentrated in the first quarter of 2026 with three distinct launches — the OMV-Based Bacterial Vaccines Development platform (January 2026), Magnetic Solid-Phase Extraction polymer magnetic particles (February 2026), and Extrahepatic RNA Delivery services (March 2026) — signaling an explicit pivot up the value chain from consumable reagents into therapeutic-enabling CRO/CDMO service offerings for pharma and biotech developers.

Short descriptiontext

CD Bioparticles is a privately held US manufacturer of magnetic particles, nanoparticles, and bead-based kits, plus custom drug delivery and vaccine development services, serving pharmaceutical, biotech, clinical, and environmental laboratories across North America and Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersShirley, United States
HQ citystring
Shirley
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
magnetic particle manufacturing, nanoparticle synthesis, drug delivery services, bead-based assay kits, biomedical research reagents
Industry4 codes
PRIMARYHLAAACAC
Non-viral Gene Delivery & Gene Therapy (LNP, polymers, electroporation, physical methods)
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
SECONDARYHLAAAEAB
Therapeutic Vaccines (cancer, chronic infection immunotherapy)
Healthcare & Life Sciences/Biotechnology & Biologics/Vaccines & Immunization Biologics
SECONDARYHLAGABAF
mRNA/LNP & Nucleic Acid Therapeutics CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAAAEAD
Vaccine Technology Platforms (mRNA, viral vector, protein subunit, inactivated/live-attenuated, VLP, DNA)
Healthcare & Life Sciences/Biotechnology & Biologics/Vaccines & Immunization Biologics
NAICS code3 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Research and Development in Nanotechnology541713
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Biomedical Research Reagents
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Product Sales (Magnetic Particles and Nanoparticles)
TypeOne Time License
Description

Direct sales of magnetic particles, nanoparticles (gold, silver, silica, polymer, quantum dots, upconverting), and beads-based kits to pharmaceutical, biotech, clinical, and environmental laboratories worldwide via e-commerce and distributors.

cd-bioparticles.com:443
2Custom Services
TypeProfessional Services
Description

Fee-for-service offerings including antibody immobilization, immunomagnetic beads preparation, drug targeting and delivery, assays development, and characterization services for specialized client needs.

cd-bioparticles.com:443
3Extrahepatic RNA Delivery Services
TypeProfessional Services
Description

Comprehensive service offering utilizing organ-targeted LNP platform with customizable targeting strategies, in vitro/in vivo validation, and safety analysis for nucleic acid therapeutics.

einpresswire.com
4OMV-Based Bacterial Vaccine Development Services
TypeProfessional Services
Description

End-to-end vaccine development services from pathogen strain acquisition and OMV extraction to engineered OMV design, quality control, and GLP-compliant preclinical evaluation.

ellwoodcityledger.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1Standard product catalog with promotional offers
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products available via e-commerce ordering with promotional 'Buy One Get One Free' offers for select products in USA, Canada, UK, Ireland, Germany, Austria, Switzerland, France, Belgium, Netherlands, and Luxembourg markets.

cd-bioparticles.com:443
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

CD Bioparticles manufactures and supplies magnetic particles, nanoparticles (gold, silver, silica, quantum dots, upconverting, polymer), and bead-based kits for biomedical applications including immune detection, isolation, drug delivery, and diagnostic assay development. The company also offers custom services such as drug targeting and delivery, antibody immobilization, assays development, and proprietary platforms including organ-targeted lipid nanoparticles for RNA delivery and outer membrane vesicle-based bacterial vaccine development.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • MSPE particles achieve 75-90% recovery rates with 15-minute workflow time
+2 more records
Product overview1 text field

CD Bioparticles is a manufacturer and supplier of magnetic particles, nanoparticles, and related laboratory products serving the pharmaceutical, biotechnology, clinical, and research sectors. The company's portfolio is organized into core product categories including Magnetic Particles (such as Absolute Mag™ Streptavidin and Gold Coated Magnetic Nanoparticles), Nanoparticles (including Spherical Gold Nanoparticles, Quantum Dots, Upconverting Nanoparticles, Fluorescent Silica Particles, and Nanozyme), Beads Based Kits and Devices, and Chromatography Resins. The portfolio features specialized sub-brands like Absolute Mag™ for magnetic particles, MagIso™ for nucleic acid isolation, and Fluorescence-Encoded Multiplex Beads for multiplexed detection. In addition to products, CD Bioparticles offers comprehensive custom services including Drug Targeting and Delivery (particularly Extrahepatic RNA Delivery Services using organ-targeted LNP platform), OMV-Based Bacterial Vaccines Development (combining synthetic biology with genome editing), Antibody Immobilization, Assays Development Services, and Characterization/Animal Model Validation. The company recently launched Magnetic Solid-Phase Extraction (MSPE) Particles for high-throughput sample preparation. Custom services are available for surface functionalization, fluorescent modification, antibody/nucleic acid conjugation, and gold nanoparticle conjugation to meet client specifications.

Product and service13 records
1Magnetic Particles
CategoryMagnetic Particles
Description

Comprehensive range of magnetic particles including Active, Affinity, Basic, Ion-exchange, Lanthanide-Based, Hydrophobe, and Silica Magnetic Particles, as well as Conjugation Kits, designed for immune detection, cell isolation, and nucleic acid extraction in laboratory and research applications.

2Nanoparticles
CategoryNanoparticles
Description

Wide range of nanoparticles including Spherical Gold Nanoparticles, Gold Nanorods, Silver Nanoparticles, Special Shape Particles, Silica Particles, Quantum Dots, Upconverting Nanoparticles, Titania Nanoparticles, Polymer Particles, Graphene and Carbon Nanotube, Agarose Particles, Additive Powders, Nanozyme, and Cellulose Nanoparticles for diagnostic, imaging, and biomedical applications.

3Beads Based Kits and Devices
CategoryAssay Kits
Description

Complete selection of kits including Chromatin Immunoprecipitation Kit, Protein Labeling/Isolation/Purification Kit, Antibody Fragmentation Kits, Bead-Based ELISA Kit, Mycotoxin Clean-up Kit, Virus Purification Kit, Homogenous Chemiluminescence Particles Based Assay Kit, Phosphoprotein Detection Kit, Pull-Down Kit, Cell Isolation, Organelles Isolation, DNA & RNA Extraction and Purification, and Immunoprecipitation Kit.

4Chromatography Resins
CategoryChromatography Resins
Description

Resins for chromatographic separation and purification applications in pharmaceutical and biotech research.

5Magnetic Solid-Phase Extraction (MSPE) Particles
CategoryMagnetic Particles
Description

Polymer magnetic particles including Absolute Mag HLB and Absolute Mag MCX products, designed for high-throughput sample preparation workflows in pharmaceutical, biotech, clinical, and environmental laboratories, featuring recovery rates of 75-90% and 15-minute workflow times compatible with automated liquid handling systems.

6Extrahepatic RNA Delivery Services
CategoryDrug Delivery Services
Description

Comprehensive services utilizing novel structured cationic and ionizable lipids with customizable targeting strategies using ligands such as antibodies and peptides, including in vitro/in vivo validation and safety/stability analysis for targeted delivery of RNA therapeutics to extrahepatic organs including lungs, spleen, brain, and lymph nodes.

7OMV-Based Bacterial Vaccines Development Platform
CategoryVaccine Development Services
Description

Advanced engineering platform combining synthetic biology with bacterial genome editing to develop scalable, safe, and immunogenic outer membrane vesicle-based bacterial vaccines for infectious disease and oncology research, with claimed production costs at least five times lower than conventional methods, providing end-to-end solutions from pathogen strain acquisition and OMV extraction to engineered OMV design, quality control, and GLP-compliant preclinical evaluation.

8Antibody Immobilization Services
CategoryCustom Services
Description

Custom services including antibody microarray printing, immobilization of antibodies on beads/macro carriers/silicon surfaces, custom gold nanoparticle conjugation, and custom upconverting nanoparticle conjugation for diagnostic and research applications.

9Assays Development Services
CategoryCustom Services
Description

Development services for latex immunoturbidimetric assay, colloidal gold lateral flow assay, quantum dot lateral flow assay, homogeneous luminescence assay, upconversion nanoparticle lateral flow assay, and magnetic particle chemiluminescent immunoassay.

10Drug Targeting and Delivery Services
CategoryDrug Delivery Services
Description

Services including nucleic acid delivery particles, magnetic sodium alginate hydrogel particles, and bio-targeted small molecules conjugated magnetic nanoparticles for drug targeting and delivery applications.

11Immunomagnetic Beads Preparation Services
CategoryCustom Services
Description

Services including magnetic beads bioconjugation and modification for immunomagnetic applications in research and diagnostics.

12Custom Imaging Contrast Agents
CategoryCustom Services
Description

Custom contrast agents for computed tomography (CT), ultrasound imaging, magnetic resonance imaging (MRI), and near-infrared (NIR) fluorescent imaging for diagnostic and research applications.

13Animal Model Validation Services
CategoryCustom Services
Description

In vivo validation services using animal models for nanoparticle and magnetic particle-based products and therapies.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialty manufacturer of polymer, magnetic, and fluorescent microparticles and nanoparticles for life science, biomedical, and diagnostic use. Directly comparable catalog and custom conjugation/CDMO services to CD Bioparticles.

TypeDirect peer
Description

Producer of polymeric and magnetic microparticles, beads, and particles for diagnostics, life science research and biomedical applications. Closely comparable specialty particle platform with custom surface functionalization.

TypeDirect peer
Description

Manufacturer of uniform microparticles and nanoparticles, including magnetic, fluorescent, and colored beads for diagnostic and research use. Directly comparable portfolio for multiplex assays and bead-based kits.

TypeDirect peer
Description

Supplier of magnetic nanoparticles, quantum dots, fluorescent nanoparticles and related products for biomedical, diagnostic, and research applications. Direct overlap on nanoparticle catalog and conjugation services.

TypeDirect peer
Description

Provider of magnetic bead-based cell separation, sample preparation, and flow cytometry solutions for biomedical research and cell therapy. Comparable magnetic bead platforms and bead-based kits for life science use.

TypeBroad incumbent
Description

Global life sciences and clinical diagnostics leader offering Bio-Plex multiplex magnetic bead assays, magnetic separators, and particle-based reagents. Broader portfolio but overlapping capability in bead-based multiplex assays and magnetic particle tools.

TypeBroad incumbent
Description

Global life science tools giant with Dynabeads magnetic bead products, particle-based reagents, and custom services across pharma, biotech, and clinical markets. Largest comparable incumbent in the magnetic particle space.

TypeBroad incumbent
Description

Major life science reagent and tools supplier offering magnetic nanoparticles, gold nanoparticles, and bead-based products. Broader catalog and global distribution but overlapping magnetic and nanoparticle product lines.

TypeBroad incumbent
Description

Scaled life sciences tools provider offering magnetic bead-based sample prep, purification and chromatography solutions serving biopharma R&D and manufacturing. Overlaps with CD Bioparticles in magnetic particle workflows and chromatography resins.

TypeEmerging player
Description

Specialty supplier of magnetic bead-based nucleic acid extraction and diagnostic sample prep products. Comparable focus on magnetic particle workflows for life science and clinical use, smaller scale than incumbent peers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CD Bioparticles

Biomedical Research Reagentscd-bioparticles.com

CD Bioparticles is a privately held US manufacturer of magnetic particles, nanoparticles, and bead-based kits, plus custom drug delivery and vaccine development services, serving pharmaceutical, biotech, clinical, and environmental laboratories across North America and Europe.

What CD Bioparticles does

CD Bioparticles is a privately held US-based manufacturer and supplier of magnetic particles, nanoparticles, and bead-based kits serving pharmaceutical, biotechnology, clinical diagnostics, and environmental testing laboratories. Headquartered in Shirley, New York, with an additional New York presence tied to its 2026 vaccine services launch, the company has operated for over 10 years and reports serving thousands of research and commercial clients globally across North America and Europe. Its portfolio spans Absolute Mag™ magnetic particles (streptavidin, affinity, ion-exchange, lanthanide-based, silica), a broad nanoparticle catalog (spherical gold, gold nanorods, silver, silica, quantum dots, upconverting nanoparticles, titania, polymer, nanozymes, cellulose), MagIso™ nucleic acid isolation particles, fluorescence-encoded multiplex beads capable of detecting up to 100 analytes simultaneously, and a comprehensive line of beads-based kits covering chromatin immunoprecipitation, ELISA, virus purification, cell isolation, and immunoprecipitation. Proprietary platform technologies include an organ-targeted lipid nanoparticle (LNP) system using novel structured cationic and ionizable lipids for extrahepatic RNA delivery and an outer membrane vesicle (OMV) engineering platform that combines synthetic biology with bacterial genome editing to produce bacterial vaccines at claimed production costs at least five times lower than conventional methods.

The company operates a hybrid go-to-market combining direct e-commerce sales through its multilingual storefront (English, German, Japanese, Korean) with a distributor network covering 11 countries and a sales-led motion for custom services such as antibody immobilization, immunomagnetic bead preparation, drug targeting and delivery, assay development (latex immunoturbidimetric, colloidal gold lateral flow, quantum dot lateral flow, chemiluminescent immunoassay), characterization, and animal model validation. Revenue is generated primarily through transactional catalog product sales (one-time purchase, pay-as-you-go with promotional bundles such as the BOGO Magnetic Rack Separator offer) and fee-for-service custom engagements, with all pricing quote-based and not publicly disclosed. Recent strategic activity has been concentrated in the first quarter of 2026 with three distinct launches — the OMV-Based Bacterial Vaccines Development platform (January 2026), Magnetic Solid-Phase Extraction polymer magnetic particles (February 2026), and Extrahepatic RNA Delivery services (March 2026) — signaling an explicit pivot up the value chain from consumable reagents into therapeutic-enabling CRO/CDMO service offerings for pharma and biotech developers.

CD Bioparticles firmographics

Firmographics
Name
CD Bioparticles
Legal name
CD Bioparticles
Website
https://cd-bioparticles.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
1–10 employees
Short description
CD Bioparticles is a privately held US manufacturer of magnetic particles, nanoparticles, and bead-based kits, plus custom drug delivery and vaccine development services, serving pharmaceutical, biotech, clinical, and environmental laboratories across North America and Europe.
Ownership category
akta.pro rank

CD Bioparticles industry classification

Industry
Product category
Biomedical Research Reagents
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Nanotechnology (541713)
SIC
Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAACAC
Non-viral Gene Delivery & Gene Therapy (LNP, polymers, electroporation, physical methods)
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
SECONDARYHLAAAEAB
Therapeutic Vaccines (cancer, chronic infection immunotherapy)
Healthcare & Life Sciences/Biotechnology & Biologics/Vaccines & Immunization Biologics
SECONDARYHLAGABAF
mRNA/LNP & Nucleic Acid Therapeutics CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAAAEAD
Vaccine Technology Platforms (mRNA, viral vector, protein subunit, inactivated/live-attenuated, VLP, DNA)
Healthcare & Life Sciences/Biotechnology & Biologics/Vaccines & Immunization Biologics

Keywords

  • Magnetic particle manufacturing
  • Nanoparticle synthesis
  • Drug delivery services
  • Bead-based assay kits
  • Biomedical research reagents

Where CD Bioparticles is headquartered

Location

Headquarters

HQ city
Shirley
HQ country
United States
HQ region
North America

Offices1 record

Markets served

CD Bioparticles business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Product Sales (Magnetic Particles and Nanoparticles): Direct sales of magnetic particles, nanoparticles (gold, silver, silica, polymer, quantum dots, upconverting), and beads-based kits to pharmaceutical, biotech, clinical, and environmental laboratories worldwide via e-commerce and distributors.
  2. Custom Services: Fee-for-service offerings including antibody immobilization, immunomagnetic beads preparation, drug targeting and delivery, assays development, and characterization services for specialized client needs.
  3. Extrahepatic RNA Delivery Services: Comprehensive service offering utilizing organ-targeted LNP platform with customizable targeting strategies, in vitro/in vivo validation, and safety analysis for nucleic acid therapeutics.
  4. OMV-Based Bacterial Vaccine Development Services: End-to-end vaccine development services from pathogen strain acquisition and OMV extraction to engineered OMV design, quality control, and GLP-compliant preclinical evaluation.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard product catalog with promotional offers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

CD Bioparticles product offering

Product offering

Core offering

CD Bioparticles manufactures and supplies magnetic particles, nanoparticles (gold, silver, silica, quantum dots, upconverting, polymer), and bead-based kits for biomedical applications including immune detection, isolation, drug delivery, and diagnostic assay development. The company also offers custom services such as drug targeting and delivery, antibody immobilization, assays development, and proprietary platforms including organ-targeted lipid nanoparticles for RNA delivery and outer membrane vesicle-based bacterial vaccine development.

Product overview

CD Bioparticles is a manufacturer and supplier of magnetic particles, nanoparticles, and related laboratory products serving the pharmaceutical, biotechnology, clinical, and research sectors. The company's portfolio is organized into core product categories including Magnetic Particles (such as Absolute Mag™ Streptavidin and Gold Coated Magnetic Nanoparticles), Nanoparticles (including Spherical Gold Nanoparticles, Quantum Dots, Upconverting Nanoparticles, Fluorescent Silica Particles, and Nanozyme), Beads Based Kits and Devices, and Chromatography Resins. The portfolio features specialized sub-brands like Absolute Mag™ for magnetic particles, MagIso™ for nucleic acid isolation, and Fluorescence-Encoded Multiplex Beads for multiplexed detection. In addition to products, CD Bioparticles offers comprehensive custom services including Drug Targeting and Delivery (particularly Extrahepatic RNA Delivery Services using organ-targeted LNP platform), OMV-Based Bacterial Vaccines Development (combining synthetic biology with genome editing), Antibody Immobilization, Assays Development Services, and Characterization/Animal Model Validation. The company recently launched Magnetic Solid-Phase Extraction (MSPE) Particles for high-throughput sample preparation. Custom services are available for surface functionalization, fluorescent modification, antibody/nucleic acid conjugation, and gold nanoparticle conjugation to meet client specifications.

Differentiator

Problem solved

Functional benefit

Products and services

  • Magnetic Particles Comprehensive range of magnetic particles including Active, Affinity, Basic, Ion-exchange, Lanthanide-Based, Hydrophobe, and Silica Magnetic Particles, as well as Conjugation Kits, designed for immune detection, cell isolation, and nucleic acid extraction in laboratory and research applications.
  • Nanoparticles Wide range of nanoparticles including Spherical Gold Nanoparticles, Gold Nanorods, Silver Nanoparticles, Special Shape Particles, Silica Particles, Quantum Dots, Upconverting Nanoparticles, Titania Nanoparticles, Polymer Particles, Graphene and Carbon Nanotube, Agarose Particles, Additive Powders, Nanozyme, and Cellulose Nanoparticles for diagnostic, imaging, and biomedical applications.
  • Beads Based Kits and Devices Complete selection of kits including Chromatin Immunoprecipitation Kit, Protein Labeling/Isolation/Purification Kit, Antibody Fragmentation Kits, Bead-Based ELISA Kit, Mycotoxin Clean-up Kit, Virus Purification Kit, Homogenous Chemiluminescence Particles Based Assay Kit, Phosphoprotein Detection Kit, Pull-Down Kit, Cell Isolation, Organelles Isolation, DNA & RNA Extraction and Purification, and Immunoprecipitation Kit.
  • Chromatography Resins Resins for chromatographic separation and purification applications in pharmaceutical and biotech research.
  • Magnetic Solid-Phase Extraction (MSPE) Particles Polymer magnetic particles including Absolute Mag HLB and Absolute Mag MCX products, designed for high-throughput sample preparation workflows in pharmaceutical, biotech, clinical, and environmental laboratories, featuring recovery rates of 75-90% and 15-minute workflow times compatible with automated liquid handling systems.
  • Extrahepatic RNA Delivery Services Comprehensive services utilizing novel structured cationic and ionizable lipids with customizable targeting strategies using ligands such as antibodies and peptides, including in vitro/in vivo validation and safety/stability analysis for targeted delivery of RNA therapeutics to extrahepatic organs including lungs, spleen, brain, and lymph nodes.
  • OMV-Based Bacterial Vaccines Development Platform Advanced engineering platform combining synthetic biology with bacterial genome editing to develop scalable, safe, and immunogenic outer membrane vesicle-based bacterial vaccines for infectious disease and oncology research, with claimed production costs at least five times lower than conventional methods, providing end-to-end solutions from pathogen strain acquisition and OMV extraction to engineered OMV design, quality control, and GLP-compliant preclinical evaluation.
  • Antibody Immobilization Services Custom services including antibody microarray printing, immobilization of antibodies on beads/macro carriers/silicon surfaces, custom gold nanoparticle conjugation, and custom upconverting nanoparticle conjugation for diagnostic and research applications.
  • Assays Development Services Development services for latex immunoturbidimetric assay, colloidal gold lateral flow assay, quantum dot lateral flow assay, homogeneous luminescence assay, upconversion nanoparticle lateral flow assay, and magnetic particle chemiluminescent immunoassay.
  • Drug Targeting and Delivery Services Services including nucleic acid delivery particles, magnetic sodium alginate hydrogel particles, and bio-targeted small molecules conjugated magnetic nanoparticles for drug targeting and delivery applications.
  • Immunomagnetic Beads Preparation Services Services including magnetic beads bioconjugation and modification for immunomagnetic applications in research and diagnostics.
  • Custom Imaging Contrast Agents Custom contrast agents for computed tomography (CT), ultrasound imaging, magnetic resonance imaging (MRI), and near-infrared (NIR) fluorescent imaging for diagnostic and research applications.
  • Animal Model Validation Services In vivo validation services using animal models for nanoparticle and magnetic particle-based products and therapies.

Quantifiable outcome

  • MSPE particles achieve 75-90% recovery rates with 15-minute workflow time
  • +2 more outcomes

Companies that use CD Bioparticles

Customer profile

Segments3 records

Ideal customer profiles3 records

CD Bioparticles technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

CD Bioparticles partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights6 records

CD Bioparticles competitors and assessment

Company assessment

Direct peers

  • Polysciences: Specialty manufacturer of polymer, magnetic, and fluorescent microparticles and nanoparticles for life science, biomedical, and diagnostic use. Directly comparable catalog and custom conjugation/CDMO services to CD Bioparticles.
  • Bangs Laboratories: Producer of polymeric and magnetic microparticles, beads, and particles for diagnostics, life science research and biomedical applications. Closely comparable specialty particle platform with custom surface functionalization.
  • Spherotech: Manufacturer of uniform microparticles and nanoparticles, including magnetic, fluorescent, and colored beads for diagnostic and research use. Directly comparable portfolio for multiplex assays and bead-based kits.
  • Ocean NanoTech: Supplier of magnetic nanoparticles, quantum dots, fluorescent nanoparticles and related products for biomedical, diagnostic, and research applications. Direct overlap on nanoparticle catalog and conjugation services.
  • Miltenyi Biotec: Provider of magnetic bead-based cell separation, sample preparation, and flow cytometry solutions for biomedical research and cell therapy. Comparable magnetic bead platforms and bead-based kits for life science use.

Broad incumbents

  • Bio-Rad Laboratories: Global life sciences and clinical diagnostics leader offering Bio-Plex multiplex magnetic bead assays, magnetic separators, and particle-based reagents. Broader portfolio but overlapping capability in bead-based multiplex assays and magnetic particle tools.
  • Thermo Fisher Scientific: Global life science tools giant with Dynabeads magnetic bead products, particle-based reagents, and custom services across pharma, biotech, and clinical markets. Largest comparable incumbent in the magnetic particle space.
  • Merck KGaA (Sigma-Aldrich): Major life science reagent and tools supplier offering magnetic nanoparticles, gold nanoparticles, and bead-based products. Broader catalog and global distribution but overlapping magnetic and nanoparticle product lines.
  • Cytiva: Scaled life sciences tools provider offering magnetic bead-based sample prep, purification and chromatography solutions serving biopharma R&D and manufacturing. Overlaps with CD Bioparticles in magnetic particle workflows and chromatography resins.

Emerging players

  • MagBio Genomics: Specialty supplier of magnetic bead-based nucleic acid extraction and diagnostic sample prep products. Comparable focus on magnetic particle workflows for life science and clinical use, smaller scale than incumbent peers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

CD Bioparticles social profiles

Digital presence

CD Bioparticles financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CD Bioparticles leadership team

Management profile

Number of profiles

CD Bioparticles funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CD Bioparticles M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CD Bioparticles

What does CD Bioparticles do?

CD Bioparticles manufactures and supplies magnetic particles, nanoparticles (gold, silver, silica, quantum dots, upconverting, polymer), and bead-based kits for biomedical applications including immune detection, isolation, drug delivery, and diagnostic assay development. The company also offers custom services such as drug targeting and delivery, antibody immobilization, assays development, and proprietary platforms including organ-targeted lipid nanoparticles for RNA delivery and outer membrane vesicle-based bacterial vaccine development.

Is CD Bioparticles a public or private company?

CD Bioparticles is a private company. It is classified as unknown and is currently operating.

When was CD Bioparticles founded?

CD Bioparticles was founded in 2009. It employs 1 to 10 people.

Where is CD Bioparticles based?

CD Bioparticles is headquartered in Shirley, United States, in the North America region.

How does CD Bioparticles make money?

Four revenue lines are on record. Product Sales (Magnetic Particles and Nanoparticles) is the primary driver. The others are custom Services, extrahepatic RNA Delivery Services and OMV-Based Bacterial Vaccine Development Services.

Who are CD Bioparticles's main competitors?

Direct peers on record are Polysciences, Bangs Laboratories, Spherotech, Ocean NanoTech and Miltenyi Biotec. Broad incumbents are Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA (Sigma-Aldrich) and Cytiva. MagBio Genomics is listed as an emerging player.

Does CD Bioparticles have an API?

No public API is recorded for CD Bioparticles.

What industry is CD Bioparticles in?

CD Bioparticles's product category is Biomedical Research Reagents. Its primary akta.pro industry code is HLAAACAC, Non-viral Gene Delivery & Gene Therapy (LNP, polymers, electroporation, physical methods), with a secondary code of HLAAAEAB, Therapeutic Vaccines (cancer, chronic infection immunotherapy). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialCD Bioparticles Offers HPV Serology Multiplex Immunoassay Services To Support Vaccine Research And Immunological StudiesCD Bioparticles launched a HPV serology multiplex immunoassay service to measure antibody responses to human papillomavirus. The platform detects antibodies against over seven oncogenic HPV subtypes in a single well, compatible with 96- and 384-well plates, and has been validated for total IgG.FinancialContent Business PageCD Bioparticles Launches Comprehensive Exosomes for Cosmetics Solutions to Advance Skincare InnovationCD Bioparticles launched a specialized Exosomes for Cosmetics product portfolio on August 31, 2026, offering plant- and cell-derived extracellular vesicles for skin barrier repair, anti-aging, hyperpigmentation reduction, and hair follicle rejuvenation. The products aim to support cosmetic manufacturers and researchers in developing advanced beauty products, with applications in skin hydration, elasticity, and customized R&D services.FinancialContent Business PageCD Bioparticles Launches Comprehensive Homogeneous Luminescence Assay Development ServicesCD Bioparticles announced its Homogeneous Luminescence Assay Development services for research applications. The service uses two types of microspheres with luminescent and photosensitizer markers to enable non-separation immunoassays, and the company has developed dozens of clinically relevant tests. It offers end-to-end support from custom conjugation to assay validation.EIN PresswireCD Bioparticles Announces Precision Custom Microneedle Mold Processing Services to Advance Transdermal Drug Delivery R&DCD Bioparticles launched a custom microneedle mold processing service to support transdermal drug delivery research. The service offers negative and positive molds for various geometries, including conical, pyramidal, and integrated arrays, for academic, formulation, and industrial use.EIN PresswireCD Bioparticles Launches Custom Services for High-Throughput Multiplex Cytokine DetectionCD Bioparticles launched custom services for high-throughput multiplex cytokine detection using magnetic fluorescent-coded microspheres. The services enable simultaneous detection of up to 50 cytokines from a single low-volume sample, supporting biomarker discovery and clinical diagnostics.EIN PresswireCD Bioparticles Launches Custom Services and Assay Kits for Detecting Cytokines with Homogeneous Luminescence AssayCD Bioparticles launched custom services and assay kits for detecting cytokines using homogeneous luminescence assay. The technology offers higher sensitivity, wider dynamic range, and no washing steps compared to ELISA, enabling rapid, high-throughput detection in cell culture supernatants or serum. The company provides development and testing services for these kits.EIN PresswireCD Bioparticles Launches Advanced Normal Organoids Kits to Accelerate 3D Biological ResearchCD Bioparticles launched Normal Organoid Kits (Human-Derived) for basic research, drug screening, toxicology, and regenerative medicine. The kits cover tissues such as intestine, lung, breast, hepatobiliary, thyroid, gastric glands, and pancreas, offering high success rates and custom services.EIN PresswireCD Bioparticles Announces Services for Colloidal Gold Lateral Flow Assays to Accelerate Point-of-Care DiagnosticsCD Bioparticles announced expanded custom services for colloidal gold lateral flow assay development, covering nanoparticle conjugation and full LFA optimization. The company provides support from feasibility studies through commercialization, including quality control and large-scale production. Services aim to help researchers transition proof-of-concept assays into rapid diagnostic solutions.EIN PresswireCD Bioparticles Launches Extrahepatic RNA Delivery Services to to Advance Nucleic Acid TherapeuticsCD Bioparticles announced the launch of comprehensive Extrahepatic RNA Delivery services designed to overcome the liver's "sink effect" that limits delivery efficiency of nucleic acid therapeutics to extrahepatic organs including the lungs, spleen, brain, and lymph nodes. The service utilizes novel structured cationic and ionizable lipids, customizable targeting strategies with ligands such as antibodies and peptides, and includes in vitro/in vivo validation as well as safety and stability analysis. Through its organ-targeted LNP platform, the company aims to expand the therapeutic application prospects of RNA therapies beyond hepatic uptake to treat a broader spectrum of diseases.The Desert SunCD Bioparticles Announces Advanced Engineering Platform for OMV-Based Bacterial Vaccine DevelopmentCD Bioparticles announced the launch of its OMV-Based Bacterial Vaccines Development services in New York, offering a new platform that combines synthetic biology with bacterial genome editing. The service aims to address limitations of traditional vaccine platforms by providing scalable, safe, and immunogenic bacterial vaccines for infectious disease and oncology research.